Award
Definitive Contract #75F40126C00088
University of Connecticut Awarded Multi-Year R&D Contract on Nano-Suspensions
Buyer
Food and Drug Administration
Award Amount
$657,981.00
Ceiling
$1,207,750.00
Awarded
September 30, 2026
Period of Performance
Sep 30, 2026 – Sep 29, 2028
Identifier
75F40126C00088
NAICS
541714
This definitive contract represents a significant multi-year research and development award granted to the University of Connecticut, a prominent academic institution located in Storrs Mansfield, CT. The contract focuses on advancing scientific understanding and predictive modeling related to the aggregation behavior of long-acting injectable nano-suspensions, a key area in pharmaceutical formulation and drug delivery research. The work involves conducting mechanistic studies and developing models that promise to enhance the design and efficacy of nano-suspension drugs. This award is crucial for the agency's mission to support innovative pharmaceutical technologies that can impact public health outcomes. The contract scope covers a three-year period with a potential extension, highlighting a sustained investment in this research domain. The contract was awarded through a formal acquisition process under the specified BAA solicitation for fiscal year 2026, signifying competitive review and selection. Given the university's research expertise, this award underscores the importance of academia-industry-government collaboration in advancing biomedical science.
Description
3-YEAR FFP CONTRACT FOR RESEARCH AND DEVELOPMENT SERVICES, BAA FY26C1CP2, MECHANISTIC INSIGHT INTO AGGREGATION BEHAVIOR AND PREDICTIVE MODELING OF LONG-ACTING INJECTABLE NANO-SUSPENSIONS.